Platelet glycoprotein IIb/IIIa inhibitors in acute ischemic stroke

Acute ischemic stroke (AIS) is a common cause of morbidity and mortality worldwide. Thrombolytic therapy with tissue plasminogen activator, the only approved treatment for AIS, is received by less than 2% of patients. Moreover, there is a slight increase in hemorrhagic complications with thrombolysi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurology India 2008-10, Vol.56 (4), p.399-404
Hauptverfasser:	Kumar, Sudhir, Rajshekher, G, Prabhakar, Subhashini
Format:	Artikel
Sprache:	eng
Schlagworte:	Abciximab, acute ischemic stroke, cerebrovascular disease, platelet glycoprotein IIb/IIIa inhibitors, tirofiban Acute Disease Angioplasty Brain Ischemia - complications Drug therapy Fibrinolytic Agents - therapeutic use Heart attacks Humans Mortality Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Stroke Stroke - drug therapy Stroke - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!